Greiner Bio-One
Greiner Bio-One provides manufacturing, distribution logistics and product application support to the world’s largest health organizations and pharmaceutical and biotechnology corporations.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
ADLM Spotlight
Gold Standard Diagnostics
Gold Standard Diagnostics is a global leader in diagnostic solutions, offering automated platforms and a comprehensive test menu across virology, bacteriology, parasitology, mycology, hormones and autoimmune diseases. We specialize in automated RPR Syphilis testing and open platforms for ELISA & CLIA.
Werfen
A Specialized Diagnostics leader, Werfen delivers innovative Hemostasis, Acute Care, Transfusion, Autoimmunity, Transplant and Immunoassay solutions to Power Patient Care. Key products: ACL TOP® Family 70 Series, HemosIL® assays, HemoHub®; GEM® Premier™ 7000
TELCOR
TELCOR is the proven leader of healthcare software solutions for point of care middleware and laboratory revenue cycle management software and services. Customers today need robust, efficient solutions to tackle laboratory and hospital challenges.
Streck
Established in 1971, Streck provides solutions that ensure every result counts by empowering clinical and research laboratories to reliably deliver accurate results, advance diagnostics and enable healthier, happier lives for patients everywhere.
Seegene Inc.
Seegene Inc., a global leader in multiplex PCR diagnostics, introduces CURECA™, a fully automated PCR platform offering true end-to-end automation from sample loading to result interpretation.
Sebia, Inc.
Sebia is a global leader in specialized in vitro diagnostics, providing instruments and reagents for screening and monitoring diseases in Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathies, Autoimmune and Infectious diseases, and other rare disorders.
Polymedco, LLC
Polymedco’s mission is to save lives through early detection of life-threatening diseases like colorectal cancer and cardiac diseases by partnering with healthcare systems, payors, providers, and reference labs to build effective screening and early detection programs.
HORIBA
Meet HORIBA in Chicago at the 2025 ADLM, Booth #328. HORIBA designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories.
HemoSonics
HemoSonics’ Quantra® Hemostasis System is revolutionizing bleeding management with its next-generation whole-blood viscoelastic analyzer.